Johnson & Johnson will acquire Shockwave Medical in a deal that would cost around $13.1 billion, paying $335 per share. The purchase will allow the company to broaden its position in the medical device field with Shockwave's intravascular lithotripsy technology used for peripheral and coronary artery disease.